Simple view

Full metadata view

Authors

Statistics

Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients

2016
journal article
article
10.1016/j.ejps.2016.05.011
Journal
European Journal of Pharmaceutical Sciences
35
Author
Maina Theodosia

Konijnenbergb Mark W.

KolencPeitl Petra

Garnuszek Piotr

Nock Berthold A.

Kaloudi Aikaterini

Kroselj Marko

Zaletel Katja

Maecke Helmut

Mansi Rosalba

Erba Paola

von Guggenberg Elisabeth

Hubalewska-Dydejczyk Alicja

Mikołajczak Renata

Decristoforo Clemens
Volume
91
Pages
236-242
ISSN
0928-0987
eISSN
1879-0720
Language
English
Container language
English
Affiliation
Wydział Lekarski : Klinika Endokrynologii
cris.lastimport.wos2024-04-10T02:52:02Z
dc.affiliationWydział Lekarski : Klinika Endokrynologiipl
dc.cm.date2020-01-07
dc.cm.id81302
dc.contributor.authorMaina, Theodosiapl
dc.contributor.authorKonijnenbergb, Mark W.pl
dc.contributor.authorKolencPeitl, Petrapl
dc.contributor.authorGarnuszek, Piotrpl
dc.contributor.authorNock, Berthold A.pl
dc.contributor.authorKaloudi, Aikaterinipl
dc.contributor.authorKroselj, Markopl
dc.contributor.authorZaletel, Katjapl
dc.contributor.authorMaecke, Helmutpl
dc.contributor.authorMansi, Rosalbapl
dc.contributor.authorErba, Paolapl
dc.contributor.authorvon Guggenberg, Elisabethpl
dc.contributor.authorHubalewska-Dydejczyk, Alicja - 129732 pl
dc.contributor.authorMikołajczak, Renatapl
dc.contributor.authorDecristoforo, Clemenspl
dc.date.accessioned2020-01-17T09:15:22Z
dc.date.available2020-01-17T09:15:22Z
dc.date.issued2016pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.physical236-242pl
dc.description.points35pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume91pl
dc.identifier.doi10.1016/j.ejps.2016.05.011pl
dc.identifier.eissn1879-0720pl
dc.identifier.issn0928-0987pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/140049
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa*
dc.rights.licenceCC-BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/legalcode.pl*
dc.share.typeinne
dc.subtypeArticlepl
dc.titlePreclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patientspl
dc.title.journalEuropean Journal of Pharmaceutical Sciencespl
dc.typeJournalArticlepl
dspace.entity.typePublication
cris.lastimport.wos
2024-04-10T02:52:02Z
dc.affiliationpl
Wydział Lekarski : Klinika Endokrynologii
dc.cm.date
2020-01-07
dc.cm.id
81302
dc.contributor.authorpl
Maina, Theodosia
dc.contributor.authorpl
Konijnenbergb, Mark W.
dc.contributor.authorpl
KolencPeitl, Petra
dc.contributor.authorpl
Garnuszek, Piotr
dc.contributor.authorpl
Nock, Berthold A.
dc.contributor.authorpl
Kaloudi, Aikaterini
dc.contributor.authorpl
Kroselj, Marko
dc.contributor.authorpl
Zaletel, Katja
dc.contributor.authorpl
Maecke, Helmut
dc.contributor.authorpl
Mansi, Rosalba
dc.contributor.authorpl
Erba, Paola
dc.contributor.authorpl
von Guggenberg, Elisabeth
dc.contributor.authorpl
Hubalewska-Dydejczyk, Alicja - 129732
dc.contributor.authorpl
Mikołajczak, Renata
dc.contributor.authorpl
Decristoforo, Clemens
dc.date.accessioned
2020-01-17T09:15:22Z
dc.date.available
2020-01-17T09:15:22Z
dc.date.issuedpl
2016
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.physicalpl
236-242
dc.description.pointspl
35
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
91
dc.identifier.doipl
10.1016/j.ejps.2016.05.011
dc.identifier.eissnpl
1879-0720
dc.identifier.issnpl
0928-0987
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/140049
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
dc.rights.licence
CC-BY
dc.rights.uri*
http://creativecommons.org/licenses/by/4.0/legalcode.pl
dc.share.type
inne
dc.subtypepl
Article
dc.titlepl
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients
dc.title.journalpl
European Journal of Pharmaceutical Sciences
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations
Wydział Lekarski
Hubalewska-Dydejczyk, Alicja
No affiliation
Maina, Theodosia
Konijnenbergb, Mark W.
KolencPeitl, Petra
Garnuszek, Piotr
Nock, Berthold A.
Kaloudi, Aikaterini
Kroselj, Marko
Zaletel, Katja
Maecke, Helmut
Mansi, Rosalba
Erba, Paola
von Guggenberg, Elisabeth
Mikołajczak, Renata
Decristoforo, Clemens

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
0
Views per month
Downloads
hubalewska-dydejczyk_et-al_preclinical_pharmacokinetics_biodistribution_2016.pdf
1

Open Access

Thumbnail Image
License
cc-by

Except as otherwise noted, this item is licensed under the Attribution 4.0 International licence

Collections
Research publications
Medical sciences
Publications of the Medical College
ROD UJ